Stocks · News reference

Tenax Therapeutics shares are trading lower after Guggenheim downgraded the stock from Buy to Neutral rating.

Aug 31, 2026, 5:29 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 31, 2026, 1:18 PMAvi Kapoor
This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst
EIX MNSO MT NVCT PCG
BenzingaAug 31, 2026, 12:55 PMBenzinga Newsdesk
Guggenheim Downgrades Tenax Therapeutics to Neutral
Guggenheim analyst Seamus Fernandez downgrades Tenax Therapeutics (NASDAQ:TENX) from Buy to Neutral.
TENX
BenzingaAug 31, 2026, 7:37 AMBenzinga Newsdesk
Reported Earlier, Tenax Reports New Phase 3 Data Supporting TNX-103 In Pulmonary Hypertension Patients
TENX